Biologics in refractory idiopathic inflammatory myositis (IIM): What experience in juvenile vs adult myositis tells us about the use of biologics in pediatric IIM
Sign Up to like & getrecommendations! Published in 2021 at "Modern Rheumatology"
DOI: 10.1080/14397595.2021.1881027
Abstract: Abstract Juvenile dermatomyositis (JDM) is an extremely heterogeneous orphan disease with limited amount of dedicated research on the subject matter. Recent research suggests that JDM may not just be the classic antibody driven complements mediated… read more here.
Keywords: biologics refractory; refractory idiopathic; treatment; juvenile ... See more keywords